HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

LFM A13

inhibits Bruton's tyrosine kinase; structure in first source
Also Known As:
LFM-A13; alpha-cyano-beta-hydroxy-beta-methyl-N-(2,5-dibromophenyl)propenamide
Networked: 13 relevant articles (4 outcomes, 3 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Uckun, Fatih M: 6 articles (12/2007 - 05/2002)
2. Vassilev, Alexei: 3 articles (01/2007 - 05/2002)
3. Dibirdik, Ilker: 2 articles (01/2011 - 01/2007)
4. Qazi, Sanjive: 2 articles (01/2011 - 01/2007)
5. Mahajan, Sandeep: 2 articles (01/2004 - 09/2003)
6. Tibbles, Heather E: 2 articles (01/2004 - 09/2003)
7. Zheng, Yaguo: 2 articles (09/2003 - 05/2002)
8. Uckun, F M: 2 articles (11/2001 - 05/2001)
9. Epstein, Joshua: 1 article (06/2013)
10. Yaccoby, Shmuel: 1 article (06/2013)

Related Diseases

1. Leukemia
2. Neoplasms (Cancer)
3. Pulmonary Embolism
4. Lymphoma (Lymphomas)
5. Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)

Related Drugs and Biologics

1. Vincristine (Oncovin)
2. Methylprednisolone
3. Asparaginase (Elspar)
4. leflunomide (Arava)
5. Phosphotransferases (Kinase)
6. Paclitaxel (Taxol)
7. Collagen
8. PCI 32765
9. R788 compound
10. bafetinib

Related Therapies and Procedures

1. Drug Therapy (Chemotherapy)